After hyperlipidemia model rats were bred with atorvastatin, HMG-CoA reductase was competitively inhibited in the liver, decreasing cholesterol synthesis and increasing low-density lipoprotein receptor synthesis. This evidence concerns the gene VLDLR and hyperlipidemia.